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Matrix-assisted laser desorption/ionization time-of-flight-mass spectrometry (MALDI-
TOF MS)-based direct-on-target microdroplet growth assay (DOT-MGA) was recently
described as a novel method of phenotypic antimicrobial susceptibility testing (AST).
Here, we developed the application of MALDI-TOF MS-based DOT-MGA for Gram-
positive bacteria including AST from agar cultures and directly from positive blood
cultures (BCs) using the detection of methicillin resistance as example. Consecutively
collected, a total of 14 methicillin-resistant Staphylococcus aureus (MRSA) and 14
methicillin-susceptible S. aureus (MSSA) clinical isolates were included. Furthermore,
a collection of MRSA challenge strains comprising different SCCmec types, mec genes,
and spa types was tested. Blood samples were spiked with MRSA and MSSA and
positive BC broth processed by three different methods: serial dilution of BC broth,
lysis/centrifugation, and differential centrifugation. Processed BC broth was directly
used for rapid AST using DOT-MGA. Droplets of 6 µl with and without cefoxitin at
the EUCAST breakpoint concentration were spotted in triplicates onto the surface of
a MALDI target. Targets were incubated in a humidity chamber, followed by medium
removal and on-target protein extraction with formic acid before adding matrix with an
internal standard as a quality control (QC). Spectra were acquired and evaluated using
MALDI Biotyper software. First, tests were considered as valid, if the growth control
achieved an identification score of ≥1.7. For valid tests, same score criterion was used
for resistant isolates when incubated with cefoxitin. An identification score <1.7 after
incubation with cefoxitin defined susceptible isolates. On-target protein extraction using
formic acid considerably improved detection of methicillin resistance in S. aureus and
DOT-MGA showed feasible results for AST from agar cultures after 4 h incubation time.
Comparing the different processing methods of positive BC broth, lysis/centrifugation
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method with a final dilution step 10−1 of the 0.5 McFarland suspension resulted in
best test performance after 4 h incubation time. Overall, 96.4% test validity, 100%
sensitivity, and 100% specificity were achieved for detection of methicillin resistance
in clinical isolates. All strains of the MRSA challenge collection were successfully tested
as methicillin-resistant. This first study on Gram-positive organisms showed feasibility
and accuracy of MALDI-TOF MS-based DOT-MGA for rapid AST of S. aureus from agar
cultures and directly from positive BCs.
Keywords: MALDI-TOF MS, direct-on-target microdroplet growth assay, antimicrobial susceptibility testing, rapid
testing, blood culture, MRSA, Staphylococcus aureus
INTRODUCTION
In times of raising antimicrobial resistance, rapid microbiological
diagnostics is important to improve patients’ outcome
(Trenholme et al., 1989; Barenfanger et al., 2008). If a timely
effective antimicrobial therapy is missing, the mortality rate
increases significantly (Kumar et al., 2006; Ferrer et al., 2014).
Particularly in case of sepsis, a rapid and accurate detection of
resistant pathogens is important (Banerjee et al., 2016; Dubourg
et al., 2018; Idelevich et al., 2018a). Bloodstream infections
are one of the most often cause of death (Singer et al., 2016).
For routine sepsis diagnostics, several rapid molecular tests
are available. However, these tests only detect the molecular
resistance mechanism and do not give reliable information on
the phenotypic resistance of the pathogen. Therefore, there is a
great call for rapid phenotypic antimicrobial susceptibility testing
(AST) in routine diagnostics (Doern, 2018; Dubourg et al., 2018;
van Belkum et al., 2019). Implementation of matrix-assisted
laser desorption/ionization time-of-flight mass spectrometry
(MALDI-TOF MS) for identification (Idelevich et al., 2014b)
and AST (Idelevich et al., 2014a) from positive blood culture
(BC) broth shortly incubated on solid medium leads to an
adjustment of empiric antibiotic therapy (Köck et al., 2017)
and has already reached the routine microbiological diagnostics
(Idelevich et al., 2019).
A MALDI-TOF MS-based direct-on-target microdroplet
growth assay (DOT-MGA) was recently developed which allows
a universal rapid AST (Idelevich et al., 2018b). It could also
be shown that rapid phenotypic detection of resistance directly
from positive BCs using DOT-MGA is feasible and accurate
(Idelevich et al., 2018c). To enable the best possible therapy
for the patient, it should be a goal to provide the results of
susceptibility testing on the same day as it is now possible for
pathogen identification (Idelevich and Becker, 2019). MALDI-
TOF MS method provides a solid basis for a method that
can do both: identification and rapid AST in one diagnostic
workflow. Direct susceptibility testing from positive BCs with
Gram-negative species by the MALDI-TOF MS-based DOT-
MGA was previously established (Idelevich et al., 2018c). In this
study, we investigate different processing methods of positive
BC broth to establish the detection of methicillin resistance in
Staphylococcus aureus directly from positive BCs using MALDI-
TOF MS-based DOT-MGA, in addition to the rapid detection
of methicillin resistance in S. aureus from cultures grown on
solid medium. Methicillin-susceptible S. aureus (MSSA) and
methicillin-resistant S. aureus (MRSA) isolates were chosen here
as an example for Gram-positive bacteria because of the high
importance of this pathogen in general and due to the special
therapeutic and infection prevention challenges of its methicillin-
and multi-resistance phenotypes (Köck et al., 2014; World Health
Organization [WHO], 2017).
MATERIALS AND METHODS
Bacterial Strains
For the study, 14 MRSA isolates were consecutively collected
in the diagnostic laboratory of the Institute of Medical
Microbiology, University Hospital Münster (Münster, Germany).
Additionally, 14 consecutive MSSA isolates were collected and
included into the study. To avoid copy isolates, only one isolate
per patient was included. For genotypic characterization, proof
of presence of mecA and mecC genes was done by GenoType
MRSA (Hain Lifescience GmbH, Nehren, Germany) according to
the manufacturer’s instructions. MSSA and MRSA isolates were
genotyped based on sequencing of the protein A gene’s (spa)
hypervariable region and spa types were assigned on the Ridom
SpaServer1 curated by the SeqNet.org initiative (Mellmann et al.,
2006). An ethical review process was not required for this study,
as patient data were neither collected nor used in this in vitro
experimental study.
Additionally, a challenge strain collection of highly diverse
MRSA strains including various SCCmec types and mec genes and
diverse spa types was selected applying isolates from the studies of
Kriegeskorte et al. (2012), Schaumburg et al. (2012), and Becker
et al. (2018). Overall, 16 isolates were chosen, comprising each
two of mecA gene-positive isolates with SCCmec types I, II, III,
IV, IVa, and V, respectively (Schaumburg et al., 2012), three mecC
gene-positive isolates with SCCmec type XI (Kriegeskorte et al.,
2012), and one plasmid-encoded mecB-positive isolate (Becker
et al., 2018) (see Supplementary Table 2).
Determination of Minimum Inhibitory
Concentration
The minimum inhibitory concentration (MIC) of cefoxitin was
determined for all isolates by broth microdilution reference
1http://spaserver.ridom.de
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method according to ISO standard 20776-1 (ISO, 2006)
corresponding to the European Committee on AST (EUCAST,
2019a) and the guidelines of the Clinical and Laboratory
Standards Institute (CLSI, 2018). Using cation-adjusted Mueller–
Hinton broth (CAMHB, BD Diagnostic, Heidelberg, Germany),
a final inoculum size of approximately 5 × 105 cfu/ml was
adjusted and confirmed by vital cell counting of serial dilutions
onto tryptic soy agar (TSA) plates in triplicates after overnight
incubation. Cefoxitin (TCI Deutschland, Eschborn, Germany)
concentrations in a range of 0.25–128 mg/L were tested in double
dilution steps. After 18 ± 2 h incubation at 35 ± 1◦C the results
were read. All tests were performed in triplicates and the median
MIC was determined. MIC results were interpreted according
to the EUCAST breakpoints (EUCAST, 2019a). MIC50, MIC90,
and MIC ranges of consecutively collected clinical isolates were
calculated for analysis. S. aureus ATCC 29213 reference strain was
used as quality control (QC).
MALDI-TOF MS-Based Rapid
Antimicrobial Susceptibility Testing From
Cultures Grown on Solid Medium
MALDI-TOF MS-based DOT-MGA was performed according
to Idelevich et al. (2018b). In brief, bacterial suspension with
standard turbidity of 0.5 McFarland (approx. 108 cfu/ml) of
an overnight culture on solid medium was prepared. The 0.5
McFarland suspension diluted 1:100 in CAMHB. A 96-well
microtiter plate was prepared; 50 µl of the diluted bacterial
suspension was added to 50 µl CAMHB as growth control.
Additionally, 50 µl diluted bacterial suspension was added
to 50 µl CAMHB containing cefoxitin, which results in a
final inoculum size of approximately 5 × 105 cfu/ml, which
is the recommended inoculum for broth microdilution by
ISO/EUCAST (ISO, 2006; EUCAST, 2019a). Final inoculum
size was confirmed by vital cell counting of serial dilutions
onto TSA plates in triplicate and counting of colonies after
overnight incubation. The final concentration of cefoxitin
was 4 mg/L, which is the breakpoint concentration dividing
between susceptible and resistant isolates, according to EUCAST
(2019a). For each isolate a growth control and a set-up
containing cefoxitin were done in triplicates, with tests performed
simultaneously on the same target. Six microliters was transferred
from each well of the microtiter plate directly onto disposable
MALDI target (MBT Biotarget 96, Bruker Daltonik GmbH,
Bremen, Germany). For each time point a separate target was
prepared. The targets were incubated in a plastic transport box
(Bruker Daltonik GmbH, Bremen, Germany) where 4 mL of
water was added to generate a humid atmosphere to avoid
evaporation of microdroplets. The boxes were incubated for
3, 4, and 5 h at 35 ± 1◦C. After incubation, the liquid
medium on top of the sedimented bacteria was removed to
avoid interference with broth ingredients during MALDI-TOF
MS measurement. While carefully touching the droplets in
a row simultaneously sidewise at its bottom on the target
surface using small filter papers (Whatman
R©
Drying Block
556, Whatman GmbH, Dassel, Germany), the medium was
removed due to capillary effects, as described in previous studies
(Idelevich et al., 2018b), but using small filter papers instead of
tissue wipes. The fully dried spots on the target were overlaid
with 1 µl 70% formic acid to disrupt the cell membrane in order
to achieve higher sensitivity and specificity for susceptibility
detection. According to the standard protocol, the dried spots
were overlaid with 1 µl MBT FAST Matrix (Bruker Daltonik
GmbH, Bremen, Germany) solved in the standard solvent
(Solution OS, LCH CHIMIE, Les Aires, France) according to the
manufacturer’s instructions.
MALDI-TOF MS-Based Rapid
Antimicrobial Susceptibility Testing
Directly From Positive Blood Cultures
Inoculation of Blood Culture Bottles
To simulate a bacteremia, 10 mL human blood (from KB,
principal investigator, own blood donation for experimental
in vitro purpose does not require this experiment to be
reviewed or approved by the local ethics committee of the
University of Münster) were spiked with a bacterial suspension
to generate a bacteremia with approximately 10 cfu/ml. In
brief, bacterial suspension with standard turbidity of 0.5
McFarland of an overnight culture on solid medium was
prepared. The standardized bacterial suspension was diluted
up to 10−5 in 1:10 dilution steps in CAMHB. 100 µl of
dilution 10−5 were mixed with 10 ml blood. Disinfection of
septum with 70% ethanol was done before and after injection.
The spiked blood was injected into an aerobic plastic culture
vial (BACTECTM Plus Aerobic/F, BD Diagnostic, Heidelberg,
Germany) and BC bottles were incubated in a BACTECTM
9240 Automated BC System (BD Diagnostic, Heidelberg,
Germany). Bacterial growth was detected using the fluorescent
sensor technology and bottles were flagged positive when
growth was detected. Time to positivity was automatically
documented. The final inoculum size of approximately 10 cfu/ml
was confirmed by vital cell counting of serial dilutions
onto TSA plates in triplicate and counting of colonies after
overnight incubation.
Processing of Positive Blood Cultures
Blood culture bottles were removed from the incubator when
flagged positive within the personnel’s working hours and
processed immediately after removal. Preliminary experiments,
done with six MRSA and six MSSA consecutively collected
clinical isolates, used modified processing methods for
isolation of bacteria from positive BCs for rapid AST,
but could not reach satisfactory results. For preliminary
experiments, each positive BC sample was processed by
filtration/dilution, dilution, lysis/centrifugation, and differential
centrifugation and DOT-MGA was incubated for 4, 5, and
6 h. Exact procedure of processing methods of preliminary
experiments is described in Supplementary Data 1. To
improve the results and processing methods of the preliminary
experiments (Supplementary Table 1) and to analyze the
best suitable method for isolation of bacteria from positive
BCs for rapid AST in this present study, positive BC of
28 S. aureus consecutively collected clinical isolates and
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additionally 16 isolates of MRSA challenge strain collection
described above were finally processed with three different
methods: dilution, lysis/centrifugation, and differential
centrifugation (Figure 1).
Dilution
Positive BC broth was diluted in decimal dilution steps up to
10−4 in CAMHB. Dilution steps 10−2,10−3, and 10−4 were
used for DOT-MGA. Real bacterial concentration in positive BC
broth was determined by vital cell counting of serial dilutions
onto TSA plates in triplicate and counting of colonies after
overnight incubation.
Lysis/centrifugation
For the lysis/centrifugation method, the MBT Sepsityper
kit (Bruker Daltonik GmbH, Bremen, Germany) was used
according to the manufacturer’s instructions (version prior to
introduction of rapid workflow and improved formulation),
but instead of 200 µl lysis buffer only 100 µl lysis buffer
was used and the obtained pellet was suspended in 1 ml
0.9% NaCl. A bacterial suspension with standard turbidity
of 0.5 McFarland was prepared. The standardized bacterial
suspension was diluted 1:10 and 1:100 in CAMHB and
both dilutions were used for DOT-MGA. The real bacterial
concentration in test was determined by vital cell counting as
described above.
Differential centrifugation
Differential centrifugation was used as a third method. To
separate the blood cells from the bacterial cells, a first low
speed centrifugation step was performed. 1.5 ml positive
BC broth was centrifuged at 2000 rpm for 2 min. 1 ml
of supernatant was transferred into a new reaction tube
and centrifuged at 13,000 rpm for 2 min. Supernatant
was discarded and the obtained pellet was suspended in
1 ml 0.9% NaCl. A bacterial suspension with standard
turbidity of 0.5 McFarland was prepared. The standardized
bacterial suspension was diluted 1:10 and 1:100 in CAMHB
and dilutions were used for DOT-MGA. Real bacterial
concentration in test was determined by vital cell counting
as described above.
MALDI-TOF MS Direct on-Target Microdroplet
Growth Assay
Three different methods for processing of positive BC broth
were performed and the resulting inoculum was used for
rapid AST by DOT-MGA. Procedure of DOT-MGA was
described above (see the section “MALDI-TOF MS-Based Rapid
Antimicrobial Susceptibility Testing From Cultures Grown
on Solid Medium”). In brief, 50 µl of cefoxitin solution
in CAMHB was added to 50 µl of bacterial suspension in
CAMHB in a well of a 96-well microtiter plate. The final
concentration of cefoxitin was 4 mg/L. Additionally, 50 µl
of bacterial suspension in CAMHB was added to 50 µl
CAMHB as a growth control. For each sample, the growth
control and the set-up containing cefoxitin were prepared
in triplicate. Six microliters of droplets of each well of the
microtiter plate was transferred directly on a hydrophilic spot
of a disposable MBT Biotarget 96 (Bruker Daltonik GmbH,
Bremen, Germany), resulting in three spots being inoculated
with the sample with cefoxitin and three spots containing
the growth control without cefoxitin for the corresponding
sample. A separate target was prepared for each time point.
The targets were incubated in a plastic transport box (Bruker
Daltonik GmbH, Bremen, Germany) where 4 ml water was
added to generate a humidity chamber. The boxes were
incubated for 3, 4, 5, and 6 h at 35 ± 1◦C. The microtiter
plate was incubated for 18 ± 2 h at 35 ± 1◦C too, as
an additional control of each experiment. After incubation,
the liquid medium was removed as described above and
dried spots were treated with 1 µl 70% formic acid and
overlaid with 1 µl MBT FAST Matrix (Bruker Daltonik
GmbH, Bremen, Germany) solved in the standard solvent.
MBT FAST Matrix contains an internal standard as a QC for
spectra acquisition.
Spectrum Acquisition and Categorization
MALDI-TOF MS measurement was performed using the
MALDI Biotyper smart instrument (Bruker Daltonik GmbH,
Bremen, Germany) and the flexControl software (Version
3.4, Bruker Daltonik GmbH, Bremen, Germany). Spectra
were acquired with optimized instrument settings for DOT-
MGA assay. Random walk and adapted acceptance criteria
of the intensity were selected. The acquired spectra were
analyzed using the MALDI Biotyper Compass Explorer
(Version 4.1; Bruker Daltonik GmbH, Bremen, Germany)
and matched against the BDAL database [Update Version
4.1 with 7854 Main Spectra (MSP) entries]. Spectra were
categorized and interpreted as previously described according
to the identification (score of ≥1.7)/no-identification
(score of <1.7) evaluation (Idelevich et al., 2018b,c).
Briefly, if the growth control without cefoxitin achieved
an identification score of ≥1.7 for the tested isolate, the
test was considered as valid. The test was invalid, if the
score of the growth control was <1.7. Valid samples
with cefoxitin and a score ≥1.7 resulted in a successful
species identification and were interpreted as resistant.
Valid samples with cefoxitin and a score <1.7 resulted in
a failed identification and were interpreted as susceptible.
In analogy to current approach for MIC determination,
median score results of three spots were calculated and
used for analysis.
Data Evaluation
Detection of growth, i.e., score ≥ 1.7, as median result of
three spots for the growth control was the criteria for a
valid test, and test validity rate was calculated. Sensitivity of
resistance detection was defined as the proportion of isolates
correctly tested as resistant by DOT-MGA method among
resistant isolates according to standard method. Specificity
was defined as the proportion of isolates correctly tested
among susceptible isolates determined by standard method.
The relationship between two variables was expressed by the
Pearson correlation coefficient (r) (Pearson, 1931, 1932). To test
if calculated correlation is statistically significant (p), Student’s
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FIGURE 1 | Different processing methods of positive blood culture broth. Dilution method was done with dilution steps up to 10-4 in CAMHB. Dilutions were directly
used for DOT-MGA. Lysis/centrifugation method was done according to the protocol of MBT Sepsityper kit (Bruker Daltonik GmbH, Bremen, Germany; version prior
to introduction of rapid workflow and improved formulation), but only 100 µl lysis buffer was used. Differential centrifugation was performed with a first centrifugation
step of 2 min at 2000 rpm and a second centrifugation step of 2 min at 13,000 rpm. Obtained pellets were resuspended and a standardized 0.5 McFarland
suspension was prepared. Two different dilutions were used for DOT-MGA.
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t-test (Student, 1908) was done and a significant level of
α = 0.05 was determined.
Spectrophotometric Measurement of
Bacterial Growth by Optical Density
Bacterial growth of positive BC broth treated with different
processing methods was analyzed by spectrophotometric
measurement using a Multi-Mode Reader (Synergy HTX,
BioTek, Bad Friedrichshall, Germany). Blood was spiked as
described above and positive BC broth was processed (i) with
differential centrifugation and a first centrifugation step of
2 min at 2000 rpm followed by a second centrifugation step
of 2 min at 13,000 rpm as pictured above. (ii) The differential
centrifugation method was modified with a first centrifugation
step of 5 min at 2000 rpm. (iii) The MBT Sepsityper kit
(Bruker Daltonik GmbH, Bremen, Germany; version prior to
introduction of rapid workflow and improved formulation)
was used according to the manufacturer’s instructions and (iv)
the MBT Sepsityper kit protocol was modified and instead
of 200 µl lysis buffer only 100 µl lysis buffer was used.
The standardized bacterial inoculum (McFarland 0.5) was
diluted 1:200, while 10 µl was added to 1990 µl CAMHB.
Dilution was directly transferred to a microtiter plate for
analysis of bacterial growth. Microtiter plate was incubated
at 37◦C for 18 h in the Multi-Mode Reader, measurement
of optical density was performed every 10 min and before
measurement the plate was shaken. Three wells of a microtiter
plate were read in parallel and mean of optical density at
578 nm was calculated.
RESULTS
Characterization of Bacterial Isolates
With Standard Methods
Using reference AST method, the cefoxitin MIC50, MIC90, and
MIC range of MSSA consecutively collected clinical isolates were
4, 4, and 2 to 4 mg/L, respectively. For consecutive clinical
MRSA isolates, cefoxitin MIC50, MIC90, and MIC range were
128, >128, and 16 to >128 mg/L, respectively. The MIC of QC
strain S. aureus ATCC 29213 was within the recommended range
of 1–4 mg/L (EUCAST, 2019b). Phenotypic susceptibility results
were confirmed by genotypic characterization. The mecA gene
was detected in all consecutive clinical MRSA isolates while the
mecC gene was not detected. Overall, 21 different spa types were
detected. One isolate each within the 14 MSSA consecutively
collected clinical isolates was spa type t002, t003, t012, t015,
t021, t032, t084, t209, t315, t1043, t2078, or t2333. Two MSSA
consecutively collected clinical isolates were spa type t091. One
isolate each within the 14 consecutive clinical MRSA isolates
was spa type t034 (livestock-associated MRSA), t045, t304, t437,
t693, t4929, or t5857. Two MRSA each were spa type t003 or
t011 (livestock-associated MRSA), respectively, and three MRSA
isolates were spa type t032. MICs and spa type distribution
for challenge strain collection isolates are demonstrated in
Supplementary Table 2.
MALDI-TOF MS Based DOT-MGA From
Cultures Grown on Solid Medium
The accuracy of rapid detection of methicillin resistance in
consecutively collected clinical isolates of S. aureus using
MALDI-TOF MS-based DOT-MGA from solid medium
overnight cultures are shown in Table 1. The best performance
of MALDI-TOF MS-based DOT-MGA was observed after 5 h
of incubation showing each 100% for sensitivity, specificity, and
test validity. The 4-h incubation provided equal percentages of
sensitivity and specificity for detection of methicillin resistance,
but only 85.7% test validity. Final inoculum size of approximately
5 × 105 cfu/ml was reached for all tested isolates (data not
shown). MRSA challenge strain collection isolates were detected
successfully after 5 or 6 h (Supplementary Table 3).
MALDI-TOF MS-Based DOT-MGA
Directly From Positive Blood Cultures
The mean determined bacterial concentration in inoculated
blood samples was 9 CFU/ml (range, 2–15 CFU/ml). The
time to positivity of BC bottles inoculated with consecutively
collected clinical MSSA isolates was 673 min on average. Bottles
inoculated with consecutive clinical MRSA isolates were flagged
as positive on average after 702 min. BC bottles were removed
from the incubator when flagged positive during the daily
working hours and processed immediately after removal. The
average times between positivity signal and processing for MSSA
was 233 and for MRSA was 217 min, respectively. The mean
bacterial concentration in positive BC was 1.5 × 109 CFU/ml
(range, 3.2 × 106–8.7 × 109 CFU/ml). It could be shown
that shorter times to positivity were linked to higher bacterial
concentrations in inoculated blood, see Supplementary Figure 1.
Additionally, higher bacterial concentrations of positive BC broth
were associated with shorter times to positivity. A relation
between bacterial concentration of inoculated blood and bacterial
concentration in positive BC broth could not be observed.
Likewise, there was no connection between determined bacterial
concentration in positive BC broth and time until processing
after positivity signal, i.e., additional incubation after positivity
(Supplementary Figure 1).
Using different processing methods for positive BC broth, the
determined final bacterial concentration in test was different.
Final real bacterial concentrations in test after processing
positive BC broth with different methods are shown in
Table 2. The mean inoculum size of lysis/centrifugation method
TABLE 1 | Rapid AST from cultures grown on solid medium.
Incubation time Validitya (%) Sensitivityb (%) Specificityb (%)
3 h 28.6 92.9 100
4 h 85.7 100 100
5 h 100 100 100
Accuracy of detection of methicillin resistance in S. aureus (consecutively collected
clinical isolates, n = 28) using MALDI-TOF MS-based DOT-MGA. aValid test –
the growth control was detected (identification score ≥1.7 for the tested isolate).
bCalculated for valid tests.
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TABLE 2 | Determined final bacterial concentrations in tests achieved with
different processing methods of positive BCs (consecutively collected clinical
isolates, n = 28).
Final concentration in test (CFU/ml)
Processing method Dilution Mean Minimum Maximum
Dilution 10−2 7.2 × 106 1.6 × 104 4.4 × 107
10−3 7.6 × 105 1.6 × 103 4.4 × 106
10−4 7.6 × 104 1.6 × 102 4.4 × 105
Lysis/centrifugation 10−2 3.8 × 104 4.8 × 103 3.6 × 105
10−1 3.8 × 105 4.8 × 104 3.6 × 106
Differential centrifugation 10−2 3.0 × 104 2.3 × 101 1.2 × 105
10−1 3.0 × 105 2.3 × 102 1.2 × 106
(10−1 dilution) and differential centrifugation method (10−1
dilution) reached on average the recommended inoculum
size of 5 × 105 CFU/ml (ISO, 2006; CLSI, 2018). Serial
dilution of positive BC broth (10−3) provided a mean
inoculum size close to this recommended inoculum size as
well. Performance of MALDI-TOF MS-based DOT-MGA for
direct detection of methicillin resistance in S. aureus from
positive BCs using different processing methods is shown in
Table 3. After 4 h of incubation time, lysis/centrifugation
method (10−1 dilution) showed best result: 100% accuracy
of detection of methicillin resistance was achieved and test
validity was 96.4%. After 6 h of incubation time, serial
dilution of positive BC broth (10−4) and lysis/centrifugation
method (10−1 dilution) showed similar accurate results at a
test validity of 96.4%. Comparing these results to results of
preliminary experiments for MALDI-TOF MS-based DOT-MGA
directly from positive BCs, that were shown in Supplementary
Table 1, a considerably improvement was shown. Using the
non-modified lysis/centrifugation method in these preliminary
experiments, no valid tests could be observed. Results of the
non-modified differential centrifugation method in preliminary
experiments showed lower validity (41.7%) compared to validity
of the modified differential centrifugation method (96.4%) after
6 h incubation time. However, even the dilution method
showed distinct improvement. All MRSA challenge strain
collection isolates were successfully detected after processing and
performing MALDI-TOF MS-based DOT-MGA directly from
positive BC (Supplementary Table 4).
DISCUSSION
For septic patients, a rapid AST directly from positive BCs would
reduce time to beginning of an effective antimicrobial therapy
and enhance patients’ outcome in comparison to standard
susceptibility testing (Kumar et al., 2006). MALDI-TOF MS’
principal feasibility as a method for rapid AST could be shown
in studies before (Lange et al., 2014). The recently developed
DOT-MGA presents a universal phenotypic rapid AST based
on MALDI-TOF MS (Idelevich et al., 2018b). MALDI-TOF
MS-based DOT-MGA is able to perform identification and
AST within few hours and could easily be implemented in TA
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routine laboratory workflows. To accelerate in particular the
diagnostics of sepsis, direct susceptibility testing from positive
BCs with Gram-negative species by the MALDI-TOF MS-based
DOT-MGA was recently established (Idelevich et al., 2018c).
Idelevich et al. (2018c) could show that rapid detection of
carbapenem non-susceptibility in Enterobacterales directly from
positive BCs was possible within 4 h using the MALDI-TOF
MS-based DOT-MGA.
In this study, we focused on the rapid detection of methicillin
resistance in S. aureus using MALDI-TOF MS, that is the first
study of using MALDI-TOF MS-based DOT-MGA for Gram-
positive species, such as S. aureus. Previous studies investigated
the use of MALDI-TOF MS for this purpose by comparing
acquired spectra of MSSA strains to spectra of MRSA strains to
identify unique mass peaks. They found different mass peaks that
were applied to differentiate MSSA and MRSA obtaining different
sensitivities and specificities of this procedure (Edwards-Jones
et al., 2000; Bernardo et al., 2002; Du et al., 2002; Wang et al.,
2013). Josten et al. (2014) identified a small peptide (PSM-mec)
produced by agr-positive strains that is part of the genomes
of health care-associated MRSA. This peptide can be detected
in the MALDI-TOF MS spectra (2415 Da) and could be used
for rapid identification of this subgroup of MRSA with high
specificity and sensitivity. However, a universal approach to
determine methicillin susceptibility is still missing. The newly
introduced MALDI-TOF MS-based DOT-MGA is a universal
phenotypic assay that offers the opportunity to distinguish
between susceptible and non-susceptible isolates in the presence
of an antibiotic agent. Here, to discriminate between MSSA and
MRSA, isolates were incubated in the presence of cefoxitin and
growth or no growth was analyzed.
To accelerate the detection of MRSA strains, we focused on
the rapid detection of methicillin resistance in S. aureus directly
from positive BCs in this study. To process positive BC broth,
three different methods were used: dilution, lysis/centrifugation,
and differential centrifugation. Preliminary experiments to this
study applied the same processing approach that Idelevich et al.
(2018c) used for detection of carbapenem non-susceptibility in
Enterobacterales. Here, results showed (Supplementary Table 1)
that dilution method was the best to detect methicillin resistance
in S. aureus directly from positive BC broth using MALDI-
TOF MS-based DOT-MGA. Lysis/centrifugation and differential
centrifugation method revealed less validity for detection of
methicillin resistance in S. aureus. Due to this, analysis of
bacterial growth by spectrophotometric measurement of optical
density for isolates of positive BC broth treated with different
processing methods was done and results showed that there was a
delayed beginning of bacterial growth (Supplementary Figure 2).
When treating positive BC broth with lysis/centrifugation
method using MBT Sepsityper (Bruker Daltonik GmbH, Bremen,
Germany) standard protocol (version prior to introduction of
rapid workflow and improved formulation) and adding 200 µl
lysis buffer to 1 ml BC broth according to the manufacturer’s
instructions instead of adding only 100 µl lysis buffer to 1 ml BC
broth, there was a delayed beginning of bacterial growth of up
to 4 h. Idelevich et al. (2018c) demonstrated the performance of
the lysis/centrifugation method for processing positive BC broth,
when using the MBT Sepsityper standard protocol adding 200 µl
lysis buffer to 1 ml blood for direct testing of carbapenem non-
susceptibility in Enterobacterales using MALDI-TOF MS-based
DOT-MGA. Gram-positive bacteria seem to be more sensitive
against lysis buffer of MBT Sepsityper comparing Gram-negative
bacteria. Due to the different cell wall structure S. aureus showed
higher susceptibility compared to Enterobacterales isolates.
Additionally, we compared two different differential
centrifugation methods (Supplementary Figure 2) one with
a first centrifugation step of 2 min at 2000 rpm and the other
with a first centrifugation step of 5 min at 2000 rpm to sediment
the blood cells. After transferring the supernatant into a new
centrifugation tube, bacteria were sedimented for 2 min at
13,000 rpm for both methods. Results showed that there was
a delayed beginning of bacterial growth of 2 h when using
a first centrifugation step of 5 min at 2000 rpm instead of
2 min. A probable explanation could be that Gram-positive
cocci like to cluster and clustered cells become heavier, heavier
cells were more sedimented when using a first centrifugation
step of 5 min instead of 2 min at 2000 rpm. Lin et al. (2017)
performed differential centrifugation method of positive BCs
to identify species using MALDI-TOF MS and could show
that identification of Gram-negative bacteria showed better
results compared to Gram-positive species after differential
centrifugation of positive BC broth.
Direct identification of species from positive BC broth using
MALDI-TOF MS was introduced several years ago and different
processing methods to treat the positive BC broth were tested
(La Scola and Raoult, 2009; Christner et al., 2010; Moussaoui
et al., 2010; Stevenson et al., 2010; Ferreira et al., 2011; Klein
et al., 2012; Zhou et al., 2017). For choosing the best processing
method of positive BC broth in our present study it is important
that in contrast to classical MALDI-TOF MS identification,
for DOT-MGA vital cells are needed for susceptibility testing.
Regarding the results of previous experiments dilution method,
lysis/centrifugation method with less lysis buffer compared to the
manufacturer’s protocol and differential centrifugation method
were chosen to have less impact on the bacterial growth for
susceptibility testing and were chosen for this study. Considering,
that MALDI-TOF MS identification results of Gram-positive
species achieved better results when performing an on-target
lysis with formic acid before adding matrix (Haigh et al., 2011),
this formic acid on-target lysis step was also performed in
this present study.
The study has shown that the rapid phenotypic AST
using MALDI-TOF MS-based DOT-MGA for detection of
methicillin resistance in subcultivated S. aureus on solid
medium is successful within 4 h with a validity of 85.7%
(Table 1), even successful detection of resistance in all MRSA
challenge strains could be shown (Supplementary Table 3).
Further results for rapid detection of methicillin resistance in
S. aureus directly from positive BCs using MALDI-TOF MS-
based DOT-MGA could reduce time to results in comparison
to the standard susceptibility testing method from subcultivated
colonies on solid medium for effective and fast sepsis diagnostics.
Results of this presented study showed best performance of
MALDI-TOF MS-based DOT-MGA for detection of methicillin
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resistance in S. aureus using modified lysis/centrifugation
protocol and using a 10−1 dilution of McFarland 0.5 suspension
to inoculate the assay (Table 3). Additionally, all MRSA
challenge strains were detected successfully after processing the
positive BC broth (Supplementary Table 4). Regarding the
determined bacterial concentrations, the mean final inoculum
was within the recommended inoculum according to EUCAST
(5 × 105 CFU/ml) if the standardized inoculum was diluted 1:10
after processing the positive BC broth with lysis/centrifugation
(3.8 × 105 CFU/ml) or differential centrifugation method
(3.0 × 105 CFU/ml). After dilution of the positive BC broth,
the recommended inoculum according to EUCAST was achieved
with the 10−3 dilution (7.6 × 105 CFU/ml). Overall, best results
of DOT-MGA in this presented study were achieved with the
inoculum recommended by EUCAST (5 × 105 CFU/ml), which
is a valid guideline for susceptibility testing. To give a general
recommendation for inoculum density for DOT-MGA further
analyses are needed.
To accelerate the diagnostic of sepsis, direct susceptibility
testing from positive BCs needs to become a suitable method
in routine laboratories. A simultaneous identification and
susceptibility testing, after previous Gram classification, would
reduce time, and an earlier start of an effective antimicrobial
therapy could decrease mortality rate. MALDI-TOF MS-based
DOT-MGA has the potential to further accelerate sepsis
diagnostics, because it is characterized by minor hands-on-time
and offers an easy and cost-efficient alternative way of rapid
AST. A further advantage of this novel method is its ability to
detect contaminations, because the correct identification of the
growth control is a validity criterion along with the sufficient
growth. An internal standard in the used MBT FAST matrix
ensured a QC for spectra acquisition. As with other routine
methods, identification and susceptibility testing by MALDI-
TOF MS is hardly possible with mixed pathogens in the BC
bottle. In this case, sub-culturing on solid medium is required
to get a pure culture for identification and susceptibility testing.
Since an increasing number of clinical microbiology laboratories
apply MALDI-TOF MS instruments for rapid identification,
rapid AST by MALDI-TOF MS could easily be integrated in
daily diagnostic workflow. Our suggested workflow is shown in
Figure 2 with lysis/centrifugation method using the modified
MBT Sepsityper protocol for species identification by MALDI-
TOF. After identification, the MALDI-TOF MS-based AST is
performed with the obtained pellet. Final susceptibility results
will be available in <6 h, starting with the positive flagged BC
and including total hands-on-time of half an hour. According
to the standard workflow in the majority of routine diagnostics
laboratories, positive BC would be subcultivated on solid medium
and, after an overnight incubation, identification is done by
MALDI-TOF MS. This is followed by standard AST, which
also requires overnight incubation. Some laboratories integrated
the identification by MALDI-TOF MS from shortly incubated
cultures on solid medium according to Idelevich et al. (2014b)
to reduce time to result. Standard workflow would take up to
2 days until susceptibility results are available, whereas results
will be available within 24 h using brief cultures on solid
medium. Rapid AST by MALDI-TOF MS DOT-MGA would
FIGURE 2 | Different workflows for susceptibility testing of positive BCs.
Classical workflow: Overnight sub-cultivation of positive BC broth, followed by
identification of the pathogen using MALDI-TOF MS. An overnight
susceptibility testing is performed and susceptibility results are finalized
approx. 2 days after BC was flagged positive. Accelerated workflow: Shortly
incubated solid medium cultures (2–6 h) are used for MALDI-TOF MS
identification, followed by an overnight susceptibility testing from the same
shortly incubated cultures. Susceptibility results are available the day after BC
was flagged positive. Suggested workflow: Positive BC broth is processed by
the lysis/centrifugation method, using the modified MBT Sepsityper protocol,
followed by the MALDI-TOF MS identification. The obtained pellet (without
protein extraction) is used for MALDI-TOF MS-based rapid AST. Susceptibility
results are available the same day BC was flagged positive within <6 h.
provide susceptibility results the same day BC was flagged
positive. MALDI-TOF MS identification before initiation of AST
provides precise guide to the choice of appropriate antibiotic
panels to be tested.
CONCLUSION
The first investigation of MALDI-TOF MS DOT-MGA for Gram-
positive bacteria demonstrated the feasibility and accuracy of
DOT-MGA from agar cultures and directly from positive BCs
for detection of methicillin resistance in S. aureus after 4 h of
incubation. To standardize and optimize test conditions and
evaluation criteria, further research is needed. An optimized
evaluation algorithm must be developed to guarantee the reliable
performance of this new rapid AST assay. Furthermore, studies
with larger amount of genetically diverse isolates from different
locations elsewhere in the world should follow to develop a
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standardized assay for clinical diagnostics. Additionally, using
this universal phenotypic assay for simultaneous rapid AST of
several antibiotics in parallel would be in focus of further studies.
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